US 11,918,350 B2
Systems, methods, and devices for rotating insulin administration sites
John Blanchard, Menlo Park, CA (US); and Sampathkumar Rangasamy, Phoenix, AZ (US)
Assigned to The Translational Genomics Research Institute, Phoenix, AZ (US)
Filed by The Translational Genomics Research Institute, Phoenix, AZ (US)
Filed on Mar. 30, 2021, as Appl. No. 17/217,711.
Claims priority of provisional application 63/003,099, filed on Mar. 31, 2020.
Prior Publication US 2021/0298650 A1, Sep. 30, 2021
Int. Cl. A61B 5/145 (2006.01); A61B 5/00 (2006.01); A61M 5/142 (2006.01); G16H 20/17 (2018.01); G16H 30/40 (2018.01)
CPC A61B 5/14532 (2013.01) [A61B 5/746 (2013.01); A61M 5/14244 (2013.01); G16H 20/17 (2018.01); G16H 30/40 (2018.01); A61M 2005/14208 (2013.01); A61M 2202/0007 (2013.01); A61M 2205/3327 (2013.01); A61M 2230/201 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A process for managing site rotation comprising:
reading, by an application running on a device, a configuration file including a group, a plurality of sites in the group, and an image associated with the group;
detecting, by the application running on the device, an input selecting a site from the plurality of sites for administration of an insulin management device;
setting, by the application running on the device, an unavailable flag for the selected site for a predetermined duration in response to the input selecting the site; and
writing, by the application running on the device, a log entry to track usage of the site in response to the input selecting the site.